My Quote Request
No products added yet
6505-01-272-2379
20 Products
TRILAFON CONCENTRATE
PERPHENAZINE ORAL SOLUTION,USP
NSN, MFG P/N
6505012722379
NSN
6505-01-272-2379
TRILAFON CONCENTRATE
PERPHENAZINE ORAL SOLUTION,USP
NSN, MFG P/N
6505012722379
NSN
6505-01-272-2379
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.000 MILLIGRAMS PERPHENAZINE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PERPHENAZINE ORAL SOLUTION 16MG/5ML 118ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00121-0673-04
PERPHENAZINE ORAL SOLUTION,USP
NSN, MFG P/N
6505012722379
NSN
6505-01-272-2379
NDC00121-0673-04
PERPHENAZINE ORAL SOLUTION,USP
NSN, MFG P/N
6505012722379
NSN
6505-01-272-2379
MFG
PHARMACEUTICAL ASSOCIATES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.000 MILLIGRAMS PERPHENAZINE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PERPHENAZINE ORAL SOLUTION 16MG/5ML 118ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
TRILAFON
PERPHENAZINE ORAL SOLUTION,USP
NSN, MFG P/N
6505012722379
NSN
6505-01-272-2379
TRILAFON
PERPHENAZINE ORAL SOLUTION,USP
NSN, MFG P/N
6505012722379
NSN
6505-01-272-2379
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 16.000 MILLIGRAMS PERPHENAZINE PER 5 MILLILITERS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PERPHENAZINE ORAL SOLUTION 16MG/5ML 118ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 FLUID OUNCES OR 118.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-1758-02
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722383
NSN
6505-01-272-2383
NDC00085-1758-02
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722383
NSN
6505-01-272-2383
MFG
CARDINAL HEALTH 200 LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXACIN HYDROCHLORIDE TABLETS 250MG I.S. 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS; UNIT DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
CIPRO
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722384
NSN
6505-01-272-2384
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXFACIN TABLETS USP 750MG 50S BT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CIPRO TABLETS
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722384
NSN
6505-01-272-2384
CIPRO TABLETS
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722384
NSN
6505-01-272-2384
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXFACIN TABLETS USP 750MG 50S BT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00026-8514-50
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722384
NSN
6505-01-272-2384
NDC00026-8514-50
CIPROFLOXACIN TABLETS,USP
NSN, MFG P/N
6505012722384
NSN
6505-01-272-2384
MFG
BAYER PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 750.000 MILLIGRAMS CIPROFLOXACIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIPROFLOXFACIN TABLETS USP 750MG 50S BT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CALCIPARINE
HEPARIN CALCIUM INJECTION,USP
NSN, MFG P/N
6505012722388
NSN
6505-01-272-2388
CALCIPARINE
HEPARIN CALCIUM INJECTION,USP
NSN, MFG P/N
6505012722388
NSN
6505-01-272-2388
MFG
DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN EQUIVALENT PER MILLILITER
ADMINISTRATION: SUBCUTANEOUS OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 0.200 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: 5000 USP HEPARIN UNITS PER PREFILLED SYRINGE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
CALCIPARINE INJECTION
HEPARIN CALCIUM INJECTION,USP
NSN, MFG P/N
6505012722388
NSN
6505-01-272-2388
CALCIPARINE INJECTION
HEPARIN CALCIUM INJECTION,USP
NSN, MFG P/N
6505012722388
NSN
6505-01-272-2388
MFG
DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN EQUIVALENT PER MILLILITER
ADMINISTRATION: SUBCUTANEOUS OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 0.200 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: 5000 USP HEPARIN UNITS PER PREFILLED SYRINGE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00056-0030-02
HEPARIN CALCIUM INJECTION,USP
NSN, MFG P/N
6505012722388
NSN
6505-01-272-2388
NDC00056-0030-02
HEPARIN CALCIUM INJECTION,USP
NSN, MFG P/N
6505012722388
NSN
6505-01-272-2388
MFG
DU PONT CRITICAL CARE INC SUB OF E I DU PONT DE NEMOURS AND CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25000.000 USP UNITS HEPARIN EQUIVALENT PER MILLILITER
ADMINISTRATION: SUBCUTANEOUS OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 0.200 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE-NEEDLE UNIT
SPECIAL FEATURES: 5000 USP HEPARIN UNITS PER PREFILLED SYRINGE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00093-3195-01
KETOPROFEN CAPSULES
NSN, MFG P/N
6505012724410
NSN
6505-01-272-4410
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS KETOPROFEN ACTIVE INGREDIENT
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOPROFEN CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-5750-01
KETOPROFEN CAPSULES
NSN, MFG P/N
6505012724410
NSN
6505-01-272-4410
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS KETOPROFEN ACTIVE INGREDIENT
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
III PART NAME ASSIGNED BY CONTROLLING AGENCY: KETOPROFEN CAPSULES 75MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00085-0806-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
NDC00085-0806-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 450.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 450MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
NDC00258-3614-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
NDC00258-3614-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
MFG
INWOOD LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 450.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 450MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
NDC50111-0518-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
NDC50111-0518-01
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
MFG
PLIVA INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 450.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 450MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
THEO-DUR
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
THEO-DUR
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 450.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 450MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
THEO-DUR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
THEO-DUR TABLETS
THEOPHYLLINE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505012725114
NSN
6505-01-272-5114
MFG
SCHERING-PLOUGH CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 450.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE TABLETS 450MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANHYDROUS
Related Searches:
ADRIAMYCIN
DOXORUBICIN HYDROCHLORIDE FOR INJECTION,USP
NSN, MFG P/N
6505012726052
NSN
6505-01-272-6052
ADRIAMYCIN
DOXORUBICIN HYDROCHLORIDE FOR INJECTION,USP
NSN, MFG P/N
6505012726052
NSN
6505-01-272-6052
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 750 MILLIGRAMS OF LACTOSE,MULT-DOSEVIAL
Related Searches:
NDC00013-1116-83
DOXORUBICIN HYDROCHLORIDE FOR INJECTION,USP
NSN, MFG P/N
6505012726052
NSN
6505-01-272-6052
NDC00013-1116-83
DOXORUBICIN HYDROCHLORIDE FOR INJECTION,USP
NSN, MFG P/N
6505012726052
NSN
6505-01-272-6052
MFG
ERBAMONT INC ADRIA LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
FEATURES PROVIDED: STERILE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 150.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: WITH 750 MILLIGRAMS OF LACTOSE,MULT-DOSEVIAL
Related Searches:
0087-08
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505012726053
NSN
6505-01-272-6053
0087-08
NORTRIPTYLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505012726053
NSN
6505-01-272-6053
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS NORTRIPTYLINE HYDROCHLORIDE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NORTRIPTYLINE HYDROCHLORIDE CAPSULES USP 25MG 500S BT
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PAMELOR BY SANDOZ PHARM DIV.
